NovaDel Pharma, Inc. (AMEX: NVD), a specialty pharmaceutical company, is focused on developing oral spray formulations of a wide array of marketed therapeutics. NovaMist™, the Company’s proprietary technology, allows drugs to be rapidly delivered directly into the bloodstream, which results in faster onset of action and may provide patient benefits in compliance, convenience and safety. Currently, NovaDel’s most advanced candidates are designed to treat angina, insomnia, and nausea. For further information, visit the Company’s web site at www.novadel.com.
- 17 years ago
QualityStocks
NovaDel Pharma, Inc. (AMEX: NVD)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Q2 2025 Revenue Jumps 154% on Strong Demand for Motion and Fast Motion Shafts
Newton Golf Company (NASDAQ: NWTG), a technology-forward golf company delivering physics-based performance innovations, reported Q2…
-
QualityStocksNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Reports Q2 2025 Results, Achieves Complete Responses in Multiple Trials, Expands AI Platform
Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharma company leveraging its RADR(R) AI/ML platform for oncology…
-
Scalability of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Tailings Model Represents Profitable Mining Approach Throughout The Americas
Sustainable mining company ESGold is stretching beyond its nascent Quebec mine tailings cleanup operation to…